Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Free phenytoin assessment in patients: measured versus calculated blood serum levels.

Tobler A, Hösli R, Mühlebach S, Huber A.

Int J Clin Pharm. 2016 Apr;38(2):303-9. doi: 10.1007/s11096-015-0241-x. Epub 2016 Jan 8.

PMID:
26746902
2.

Prevention trial in the Cherokee Nation: design of a randomized community trial.

Komro KA, Wagenaar AC, Boyd M, Boyd BJ, Kominsky T, Pettigrew D, Tobler AL, Lynne-Landsman SD, Livingston MD, Livingston B, Molina MM.

Prev Sci. 2015 Feb;16(2):291-300. doi: 10.1007/s11121-014-0478-y.

3.

Beyond the clinic: improving child health through evidence-based community development.

Komro KA, Tobler AL, Delisle AL, O'Mara RJ, Wagenaar AC.

BMC Pediatr. 2013 Oct 21;13:172. doi: 10.1186/1471-2431-13-172. Review.

4.

Intravenous phenytoin: a retrospective analysis of Bayesian forecasting versus conventional dosing in patients.

Tobler A, Mühlebach S.

Int J Clin Pharm. 2013 Oct;35(5):790-7. doi: 10.1007/s11096-013-9809-5. Epub 2013 Jun 29.

PMID:
23812678
5.

A quantitative phenytoin GC-MS method and its validation for samples from human ex situ brain microdialysis, blood and saliva using solid-phase extraction.

Hösli R, Tobler A, König S, Mühlebach S.

J Anal Toxicol. 2013 Mar;37(2):102-9. doi: 10.1093/jat/bks137. Epub 2013 Jan 16.

6.

Perceived racial/ethnic discrimination, problem behaviors, and mental health among minority urban youth.

Tobler AL, Maldonado-Molina MM, Staras SA, O'Mara RJ, Livingston MD, Komro KA.

Ethn Health. 2013;18(4):337-49. doi: 10.1080/13557858.2012.730609. Epub 2012 Oct 9.

7.

Marriage risk of cancer research fellows.

Fey MF, Tobler A.

Lancet. 2011 Dec 17;378(9809):2070. doi: 10.1016/S0140-6736(11)61898-9. No abstract available.

PMID:
22177511
8.

Transcriptional regulation of MIR29B by PU.1 (SPI1) and MYC during neutrophil differentiation of acute promyelocytic leukaemia cells.

Batliner J, Buehrer E, Federzoni EA, Jenal M, Tobler A, Torbett BE, Fey MF, Tschan MP.

Br J Haematol. 2012 Apr;157(2):270-4. doi: 10.1111/j.1365-2141.2011.08964.x. Epub 2011 Dec 7. No abstract available.

PMID:
22145969
9.

Racial/ethnic differences in the etiology of alcohol use among urban adolescents.

Tobler AL, Livingston MD, Komro KA.

J Stud Alcohol Drugs. 2011 Sep;72(5):799-810.

10.

Deregulated expression of Kruppel-like factors in acute myeloid leukemia.

Humbert M, Halter V, Shan D, Laedrach J, Leibundgut EO, Baerlocher GM, Tobler A, Fey MF, Tschan MP.

Leuk Res. 2011 Jul;35(7):909-13. doi: 10.1016/j.leukres.2011.03.010. Epub 2011 Apr 5.

PMID:
21470678
11.

Preventing the link between SES and high-risk behaviors: "value-added" education, drug use and delinquency in high-risk, urban schools.

Tobler AL, Komro KA, Dabroski A, Aveyard P, Markham WA.

Prev Sci. 2011 Jun;12(2):211-21. doi: 10.1007/s11121-011-0206-9.

12.

Contemporary options for longitudinal follow-up: lessons learned from a cohort of urban adolescents.

Tobler AL, Komro KA.

Eval Program Plann. 2011 May;34(2):87-96. doi: 10.1016/j.evalprogplan.2010.12.002. Epub 2010 Dec 30.

13.

Effects of beverage-specific alcohol consumption on drinking behaviors among urban youth.

Maldonado-Molina MM, Reingle JM, Tobler AL, Komro KA.

J Drug Educ. 2010;40(3):265-80.

14.

The ICF as a way to specify goals and to assess the outcome of physiotherapeutic interventions in the acute hospital.

Huber EO, Tobler A, Gloor-Juzi T, Grill E, Gubler-Gut B.

J Rehabil Med. 2011 Jan;43(2):174-7. doi: 10.2340/16501977-0629.

15.

Riskier sexual partners contribute to the increased rate of sexually transmitted diseases among youth with substance use disorders.

Staras SA, Tobler AL, Maldonado-Molina MM, Cook RL.

Sex Transm Dis. 2011 May;38(5):413-8. doi: 10.1097/OLQ.0b013e31820279a7.

16.

Trajectories of Physical Aggression Among Hispanic Urban Adolescents and Young Adults: An Application of Latent Trajectory Modeling from Ages 12 to 18.

Maldonado-Molina MM, Reingle JM, Tobler AL, Jennings WG, Komro KA.

Am J Crim Justice. 2010 Apr 14;35(3):121-133.

17.

Developmental constraints on the evolution of wing-body allometry in Manduca sexta.

Tobler A, Nijhout HF.

Evol Dev. 2010 Nov-Dec;12(6):592-600. doi: 10.1111/j.1525-142X.2010.00444.x.

PMID:
21040425
18.

Assessing the victim-offender overlap among Puerto Rican youth.

Maldonado-Molina MM, Jennings WG, Tobler AL, Piquero AR, Canino G.

J Crim Justice. 2010 Nov-Dec;38(6):1191-1201.

19.

Effects of alcohol tax and price policies on morbidity and mortality: a systematic review.

Wagenaar AC, Tobler AL, Komro KA.

Am J Public Health. 2010 Nov;100(11):2270-8. doi: 10.2105/AJPH.2009.186007. Epub 2010 Sep 23. Review.

20.

A switch in the control of growth of the wing imaginal disks of Manduca sexta.

Tobler A, Nijhout HF.

PLoS One. 2010 May 19;5(5):e10723. doi: 10.1371/journal.pone.0010723.

21.

Trajectories or parental monitoring and communication and effects on drug use among urban young adolescents.

Tobler AL, Komro KA.

J Adolesc Health. 2010 Jun;46(6):560-8. doi: 10.1016/j.jadohealth.2009.12.008. Epub 2010 Feb 11.

22.

The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1.

Jenal M, Batliner J, Reddy VA, Haferlach T, Tobler A, Fey MF, Torbett BE, Tschan MP.

Leukemia. 2010 May;24(5):1073-6. doi: 10.1038/leu.2010.26. Epub 2010 Mar 4. No abstract available.

PMID:
20200559
23.

Epigallocatechin-3-gallate induces cell death in acute myeloid leukaemia cells and supports all-trans retinoic acid-induced neutrophil differentiation via death-associated protein kinase 2.

Britschgi A, Simon HU, Tobler A, Fey MF, Tschan MP.

Br J Haematol. 2010 Apr;149(1):55-64. doi: 10.1111/j.1365-2141.2009.08040.x. Epub 2010 Jan 20.

PMID:
20096012
24.

Relationships between drinking onset, alcohol use intensity, and nighttime risk behaviors in a college bar district.

Thombs DL, O'Mara R, Tobler AL, Wagenaar AC, Clapp JD.

Am J Drug Alcohol Abuse. 2009;35(6):421-8. doi: 10.3109/00952990903414501.

PMID:
20014911
25.

NDRG1/2 expression is inhibited in primary acute myeloid leukemia.

Tschan MP, Shan D, Laedrach J, Eyholzer M, Leibundgut EO, Baerlocher GM, Tobler A, Stroka D, Fey MF.

Leuk Res. 2010 Mar;34(3):393-8. doi: 10.1016/j.leukres.2009.08.037. Epub 2009 Sep 22.

PMID:
19775754
26.

Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98).

Zenhäusern R, Schmitz SF, Solenthaler M, Heim D, Meyer-Monard S, Hess U, Leoncini L, Bargetzi M, Rufener B, Tobler A.

Leuk Lymphoma. 2009 Sep;50(9):1501-11. doi: 10.1080/10428190903131755.

PMID:
19672771
27.

Effects of alcohol use initiation patterns on high-risk behaviors among urban, low-income, young adolescents.

Komro KA, Tobler AL, Maldonado-Molina MM, Perry CL.

Prev Sci. 2010 Mar;11(1):14-23. doi: 10.1007/s11121-009-0144-y.

28.

Early adolescent, multi-ethnic, urban youth's exposure to patterns of alcohol-related neighborhood characteristics.

Tobler AL, Komro KA, Maldonado-Molina MM.

J Community Health. 2009 Oct;34(5):361-9. doi: 10.1007/s10900-009-9168-2.

29.

The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.

Jenal M, Trinh E, Britschgi C, Britschgi A, Roh V, Vorburger SA, Tobler A, Leprince D, Fey MF, Helin K, Tschan MP.

Mol Cancer Res. 2009 Jun;7(6):916-22. doi: 10.1158/1541-7786.MCR-08-0359. Epub 2009 Jun 2.

30.

Relationship between neighborhood context, family management practices and alcohol use among urban, multi-ethnic, young adolescents.

Tobler AL, Komro KA, Maldonado-Molina MM.

Prev Sci. 2009 Dec;10(4):313-24. doi: 10.1007/s11121-009-0133-1.

31.

Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia: a multicentre trial SAKK 32/95.

Zenhäusern R, Von Rohr A, Rufibach K, Solenthaler M, Meyer-Monard S, Gratwohl A, Hess U, Bargetzi MJ, Kovacsovic T, Leoncini L, Tobler A; Swiss Group for Clinical Cancer Research (SAKK).

Leuk Lymphoma. 2009 Jan;50(1):133-6. doi: 10.1080/10428190802527681. No abstract available.

PMID:
19152171
32.

Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98).

Zenhäusern R, Simcock M, Gratwohl A, Hess U, Bargetzi M, Tobler A; Swiss Group for Clinical Cancer Research (SAKK).

Haematologica. 2008 Sep;93(9):1426-8. doi: 10.3324/haematol.11564. Epub 2008 Jul 4. No abstract available.

33.

DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic function.

Britschgi A, Trinh E, Rizzi M, Jenal M, Ress A, Tobler A, Fey MF, Helin K, Tschan MP.

Oncogene. 2008 Sep 25;27(43):5706-16. doi: 10.1038/onc.2008.179. Epub 2008 Jun 2.

PMID:
18521079
34.

HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiation.

Britschgi C, Jenal M, Rizzi M, Mueller BU, Torbett BE, Andres AC, Tobler A, Fey MF, Tschan MP.

Br J Haematol. 2008 Apr;141(2):179-87. doi: 10.1111/j.1365-2141.2008.06992.x. Epub 2008 Mar 3.

PMID:
18318772
35.

Effects of legal BAC limits on fatal crash involvement: analyses of 28 states from 1976 through 2002.

Wagenaar AC, Maldonado-Molina MM, Ma L, Tobler AL, Komro KA.

J Safety Res. 2007;38(5):493-9. Epub 2007 Sep 29.

PMID:
18023634
36.

The hDMP1 tumor suppressor is a new WT1 target in myeloid leukemias.

Tschan MP, Gullberg U, Shan D, Torbett BE, Fey MF, Tobler A.

Leukemia. 2008 May;22(5):1087-90. Epub 2007 Nov 1. No abstract available.

PMID:
17972942
37.

General deterrence effects of U.S. statutory DUI fine and jail penalties: long-term follow-up in 32 states.

Wagenaar AC, Maldonado-Molina MM, Erickson DJ, Ma L, Tobler AL, Komro KA.

Accid Anal Prev. 2007 Sep;39(5):982-94. Epub 2007 Mar 21.

PMID:
17854574
38.

Effects of home access and availability of alcohol on young adolescents' alcohol use.

Komro KA, Maldonado-Molina MM, Tobler AL, Bonds JR, Muller KE.

Addiction. 2007 Oct;102(10):1597-608.

PMID:
17854336
39.

The death-associated protein kinase 2 is up-regulated during normal myeloid differentiation and enhances neutrophil maturation in myeloid leukemic cells.

Rizzi M, Tschan MP, Britschgi C, Britschgi A, Hügli B, Grob TJ, Leupin N, Mueller BU, Simon HU, Ziemiecki A, Torbett BE, Fey MF, Tobler A.

J Leukoc Biol. 2007 Jun;81(6):1599-608. Epub 2007 Mar 8.

PMID:
17347302
40.

Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia.

Hehlmann R, Berger U, Pfirrmann M, Heimpel H, Hochhaus A, Hasford J, Kolb HJ, Lahaye T, Maywald O, Reiter A, Hossfeld DK, Huber C, Löffler H, Pralle H, Queisser W, Tobler A, Nerl C, Solenthaler M, Goebeler ME, Griesshammer M, Fischer T, Kremers S, Eimermacher H, Pfreundschuh M, Hirschmann WD, Lechner K, Wassmann B, Falge C, Kirchner HH, Gratwohl A.

Blood. 2007 Jun 1;109(11):4686-92. Epub 2007 Feb 22.

41.

The control of growth and differentiation of the wing imaginal disks of Manduca sexta.

Nijhout HF, Smith WA, Schachar I, Subramanian S, Tobler A, Grunert LW.

Dev Biol. 2007 Feb 15;302(2):569-76. Epub 2006 Oct 21.

42.

Hematopoietic and endothelial progenitor cell trafficking in patients with myeloproliferative diseases.

Oppliger Leibundgut E, Horn MP, Brunold C, Pfanner-Meyer B, Marti D, Hirsiger H, Tobler A, Zwicky C.

Haematologica. 2006 Nov;91(11):1465-72.

43.

Gene expression profiling reveals consistent differences between clinical samples of human leukaemias and their model cell lines.

Leupin N, Kuhn A, Hügli B, Grob TJ, Jaggi R, Tobler A, Delorenzi M, Fey MF.

Br J Haematol. 2006 Nov;135(4):520-3.

44.

The SNPlex genotyping system: a flexible and scalable platform for SNP genotyping.

Tobler AR, Short S, Andersen MR, Paner TM, Briggs JC, Lambert SM, Wu PP, Wang Y, Spoonde AY, Koehler RT, Peyret N, Chen C, Broomer AJ, Ridzon DA, Zhou H, Hoo BS, Hayashibara KC, Leong LN, Ma CN, Rosenblum BB, Day JP, Ziegle JS, De La Vega FM, Rhodes MD, Hennessy KM, Wenz HM.

J Biomol Tech. 2005 Dec;16(4):398-406.

45.

Localization of Müllerian mimicry genes on a dense linkage map of Heliconius erato.

Kapan DD, Flanagan NS, Tobler A, Papa R, Reed RD, Gonzalez JA, Restrepo MR, Martinez L, Maldonado K, Ritschoff C, Heckel DG, McMillan WO.

Genetics. 2006 Jun;173(2):735-57. Epub 2006 Feb 19.

46.

Cytogenetic response to prior treatment with interferon-alpha is predictive for survival after allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia.

Maywald O, Pfirrmann M, Berger U, Breitscheidel L, Gratwohl A, Kolb HJ, Beelen DW, Tobler A, Metzgeroth G, Gnad SU, Hochhaus A, Hasford J, Hehlmann R, Reiter A; German CML Study Group; Swiss Group of Clinical Cancer Research.

Leukemia. 2006 Mar;20(3):477-84.

PMID:
16453005
47.

Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1.

Britschgi C, Rizzi M, Grob TJ, Tschan MP, Hügli B, Reddy VA, Andres AC, Torbett BE, Tobler A, Fey MF.

Oncogene. 2006 Mar 30;25(14):2030-9.

PMID:
16301995
48.

Progenitor cell trafficking in physiologic conditions and in myeloproliferative diseases: quantification of CD34+ cells by polymerase chain reaction.

Oppliger Leibundgut E, Brunold C, Marti D, Horn MP, Seiler C, Schroeder V, Schmid JP, Tobler A, Zwicky C.

Haematologica. 2005 Jul;90(7):875-80.

49.

Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases.

Beyer V, Mühlematter D, Parlier V, Cabrol C, Bougeon-Mamin S, Solenthaler M, Tobler A, Pugin P, Gregor M, Hitz F, Hess U, Chapuis B, Laurencet F, Schanz U, Schmidt PM, van Melle G, Jotterand M.

Cancer Genet Cytogenet. 2005 Jul 15;160(2):97-119. Review.

PMID:
15993266
50.

Supplemental Content

Loading ...
Support Center